Clostridial diseases are the infectious condition in animals and humans resulting from Clostridium species. It is a bacterial infection usually found in soil and organic materials. The disease caused in cattle through punctured wounds and contaminated food, which trigger the various factors and damage body tissues activating latent spores, followed by very rapid multiplication in the animal's body with toxin production, causing death within hours. But it can spread through animal to animals. The toxin may cause neuronal dysfunction and gastrointestinal tract damage.
The global market for Clostridial Diseases was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Clostridial Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clostridial Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Clostridial Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Clostridial Diseases include Boehringer Ingelheim International GmbH, Zoetis, Elanco, Merck & Co. Inc, Phibro Animal Health Corporation, Virbac, Vetoquinol, HIPRA and Ceva, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clostridial Diseases, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Clostridial Diseases by region & country, by Type, and by Application.
The Clostridial Diseases market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clostridial Diseases.
Market Segmentation
By Company
Boehringer Ingelheim International GmbH
Zoetis
Elanco
Merck & Co. Inc
Phibro Animal Health Corporation
Virbac
Vetoquinol
HIPRA
Ceva
Dechra
Kyoritsuseiyaku Corporation
Endovac Animal Health
Zydus Group
Indian Immunologicals Pvt. Ltd
UCBVET Sa煤de e Bem Estar Animal
American Reagent Inc
Neogen Corporation
Huvepharma
China Animal Husbandry Group
Segment by Type:
Tetanus toxoid
Multivalent Vaccine
Antibiotics
Segment by Application
Humanity
Animal
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Clostridial Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Clostridial Diseases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Clostridial Diseases in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Clostridial Diseases Product Introduction
1.2 Global Clostridial Diseases Market Size Forecast
1.2.1 Global Clostridial Diseases Sales Value (2019-2030)
1.2.2 Global Clostridial Diseases Sales Volume (2019-2030)
1.2.3 Global Clostridial Diseases Sales Price (2019-2030)
1.3 Clostridial Diseases Market Trends & Drivers
1.3.1 Clostridial Diseases Industry Trends
1.3.2 Clostridial Diseases Market Drivers & Opportunity
1.3.3 Clostridial Diseases Market Challenges
1.3.4 Clostridial Diseases Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Clostridial Diseases Players Revenue Ranking (2023)
2.2 Global Clostridial Diseases Revenue by Company (2019-2024)
2.3 Global Clostridial Diseases Players Sales Volume Ranking (2023)
2.4 Global Clostridial Diseases Sales Volume by Company Players (2019-2024)
2.5 Global Clostridial Diseases Average Price by Company (2019-2024)
2.6 Key Manufacturers Clostridial Diseases Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Clostridial Diseases Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Clostridial Diseases
2.9 Clostridial Diseases Market Competitive Analysis
2.9.1 Clostridial Diseases Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Clostridial Diseases Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clostridial Diseases as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tetanus toxoid
3.1.2 Multivalent Vaccine
3.1.3 Antibiotics
3.2 Global Clostridial Diseases Sales Value by Type
3.2.1 Global Clostridial Diseases Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Clostridial Diseases Sales Value, by Type (2019-2030)
3.2.3 Global Clostridial Diseases Sales Value, by Type (%) (2019-2030)
3.3 Global Clostridial Diseases Sales Volume by Type
3.3.1 Global Clostridial Diseases Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Clostridial Diseases Sales Volume, by Type (2019-2030)
3.3.3 Global Clostridial Diseases Sales Volume, by Type (%) (2019-2030)
3.4 Global Clostridial Diseases Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Humanity
4.1.2 Animal
4.2 Global Clostridial Diseases Sales Value by Application
4.2.1 Global Clostridial Diseases Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Clostridial Diseases Sales Value, by Application (2019-2030)
4.2.3 Global Clostridial Diseases Sales Value, by Application (%) (2019-2030)
4.3 Global Clostridial Diseases Sales Volume by Application
4.3.1 Global Clostridial Diseases Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Clostridial Diseases Sales Volume, by Application (2019-2030)
4.3.3 Global Clostridial Diseases Sales Volume, by Application (%) (2019-2030)
4.4 Global Clostridial Diseases Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Clostridial Diseases Sales Value by Region
5.1.1 Global Clostridial Diseases Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Clostridial Diseases Sales Value by Region (2019-2024)
5.1.3 Global Clostridial Diseases Sales Value by Region (2025-2030)
5.1.4 Global Clostridial Diseases Sales Value by Region (%), (2019-2030)
5.2 Global Clostridial Diseases Sales Volume by Region
5.2.1 Global Clostridial Diseases Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Clostridial Diseases Sales Volume by Region (2019-2024)
5.2.3 Global Clostridial Diseases Sales Volume by Region (2025-2030)
5.2.4 Global Clostridial Diseases Sales Volume by Region (%), (2019-2030)
5.3 Global Clostridial Diseases Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Clostridial Diseases Sales Value, 2019-2030
5.4.2 North America Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Clostridial Diseases Sales Value, 2019-2030
5.5.2 Europe Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Clostridial Diseases Sales Value, 2019-2030
5.6.2 Asia Pacific Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Clostridial Diseases Sales Value, 2019-2030
5.7.2 South America Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Clostridial Diseases Sales Value, 2019-2030
5.8.2 Middle East & Africa Clostridial Diseases Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Clostridial Diseases Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Clostridial Diseases Sales Value
6.2.1 Key Countries/Regions Clostridial Diseases Sales Value, 2019-2030
6.2.2 Key Countries/Regions Clostridial Diseases Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Clostridial Diseases Sales Value, 2019-2030
6.3.2 United States Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Clostridial Diseases Sales Value, 2019-2030
6.4.2 Europe Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Clostridial Diseases Sales Value, 2019-2030
6.5.2 China Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.5.3 China Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Clostridial Diseases Sales Value, 2019-2030
6.6.2 Japan Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Clostridial Diseases Sales Value, 2019-2030
6.7.2 South Korea Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Clostridial Diseases Sales Value, 2019-2030
6.8.2 Southeast Asia Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Clostridial Diseases Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Clostridial Diseases Sales Value, 2019-2030
6.9.2 India Clostridial Diseases Sales Value by Type (%), 2023 VS 2030
6.9.3 India Clostridial Diseases Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boehringer Ingelheim International GmbH
7.1.1 Boehringer Ingelheim International GmbH Company Information
7.1.2 Boehringer Ingelheim International GmbH Introduction and Business Overview
7.1.3 Boehringer Ingelheim International GmbH Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Boehringer Ingelheim International GmbH Clostridial Diseases Product Offerings
7.1.5 Boehringer Ingelheim International GmbH Recent Development
7.2 Zoetis
7.2.1 Zoetis Company Information
7.2.2 Zoetis Introduction and Business Overview
7.2.3 Zoetis Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Zoetis Clostridial Diseases Product Offerings
7.2.5 Zoetis Recent Development
7.3 Elanco
7.3.1 Elanco Company Information
7.3.2 Elanco Introduction and Business Overview
7.3.3 Elanco Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Elanco Clostridial Diseases Product Offerings
7.3.5 Elanco Recent Development
7.4 Merck & Co. Inc
7.4.1 Merck & Co. Inc Company Information
7.4.2 Merck & Co. Inc Introduction and Business Overview
7.4.3 Merck & Co. Inc Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merck & Co. Inc Clostridial Diseases Product Offerings
7.4.5 Merck & Co. Inc Recent Development
7.5 Phibro Animal Health Corporation
7.5.1 Phibro Animal Health Corporation Company Information
7.5.2 Phibro Animal Health Corporation Introduction and Business Overview
7.5.3 Phibro Animal Health Corporation Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Phibro Animal Health Corporation Clostridial Diseases Product Offerings
7.5.5 Phibro Animal Health Corporation Recent Development
7.6 Virbac
7.6.1 Virbac Company Information
7.6.2 Virbac Introduction and Business Overview
7.6.3 Virbac Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Virbac Clostridial Diseases Product Offerings
7.6.5 Virbac Recent Development
7.7 Vetoquinol
7.7.1 Vetoquinol Company Information
7.7.2 Vetoquinol Introduction and Business Overview
7.7.3 Vetoquinol Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Vetoquinol Clostridial Diseases Product Offerings
7.7.5 Vetoquinol Recent Development
7.8 HIPRA
7.8.1 HIPRA Company Information
7.8.2 HIPRA Introduction and Business Overview
7.8.3 HIPRA Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.8.4 HIPRA Clostridial Diseases Product Offerings
7.8.5 HIPRA Recent Development
7.9 Ceva
7.9.1 Ceva Company Information
7.9.2 Ceva Introduction and Business Overview
7.9.3 Ceva Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Ceva Clostridial Diseases Product Offerings
7.9.5 Ceva Recent Development
7.10 Dechra
7.10.1 Dechra Company Information
7.10.2 Dechra Introduction and Business Overview
7.10.3 Dechra Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Dechra Clostridial Diseases Product Offerings
7.10.5 Dechra Recent Development
7.11 Kyoritsuseiyaku Corporation
7.11.1 Kyoritsuseiyaku Corporation Company Information
7.11.2 Kyoritsuseiyaku Corporation Introduction and Business Overview
7.11.3 Kyoritsuseiyaku Corporation Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Kyoritsuseiyaku Corporation Clostridial Diseases Product Offerings
7.11.5 Kyoritsuseiyaku Corporation Recent Development
7.12 Endovac Animal Health
7.12.1 Endovac Animal Health Company Information
7.12.2 Endovac Animal Health Introduction and Business Overview
7.12.3 Endovac Animal Health Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Endovac Animal Health Clostridial Diseases Product Offerings
7.12.5 Endovac Animal Health Recent Development
7.13 Zydus Group
7.13.1 Zydus Group Company Information
7.13.2 Zydus Group Introduction and Business Overview
7.13.3 Zydus Group Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Zydus Group Clostridial Diseases Product Offerings
7.13.5 Zydus Group Recent Development
7.14 Indian Immunologicals Pvt. Ltd
7.14.1 Indian Immunologicals Pvt. Ltd Company Information
7.14.2 Indian Immunologicals Pvt. Ltd Introduction and Business Overview
7.14.3 Indian Immunologicals Pvt. Ltd Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Indian Immunologicals Pvt. Ltd Clostridial Diseases Product Offerings
7.14.5 Indian Immunologicals Pvt. Ltd Recent Development
7.15 UCBVET Sa煤de e Bem Estar Animal
7.15.1 UCBVET Sa煤de e Bem Estar Animal Company Information
7.15.2 UCBVET Sa煤de e Bem Estar Animal Introduction and Business Overview
7.15.3 UCBVET Sa煤de e Bem Estar Animal Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.15.4 UCBVET Sa煤de e Bem Estar Animal Clostridial Diseases Product Offerings
7.15.5 UCBVET Sa煤de e Bem Estar Animal Recent Development
7.16 American Reagent Inc
7.16.1 American Reagent Inc Company Information
7.16.2 American Reagent Inc Introduction and Business Overview
7.16.3 American Reagent Inc Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.16.4 American Reagent Inc Clostridial Diseases Product Offerings
7.16.5 American Reagent Inc Recent Development
7.17 Neogen Corporation
7.17.1 Neogen Corporation Company Information
7.17.2 Neogen Corporation Introduction and Business Overview
7.17.3 Neogen Corporation Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Neogen Corporation Clostridial Diseases Product Offerings
7.17.5 Neogen Corporation Recent Development
7.18 Huvepharma
7.18.1 Huvepharma Company Information
7.18.2 Huvepharma Introduction and Business Overview
7.18.3 Huvepharma Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Huvepharma Clostridial Diseases Product Offerings
7.18.5 Huvepharma Recent Development
7.19 China Animal Husbandry Group
7.19.1 China Animal Husbandry Group Company Information
7.19.2 China Animal Husbandry Group Introduction and Business Overview
7.19.3 China Animal Husbandry Group Clostridial Diseases Sales, Revenue and Gross Margin (2019-2024)
7.19.4 China Animal Husbandry Group Clostridial Diseases Product Offerings
7.19.5 China Animal Husbandry Group Recent Development
8 Industry Chain Analysis
8.1 Clostridial Diseases Industrial Chain
8.2 Clostridial Diseases Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Clostridial Diseases Sales Model
8.5.2 Sales Channel
8.5.3 Clostridial Diseases Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Boehringer Ingelheim International GmbH
Zoetis
Elanco
Merck & Co. Inc
Phibro Animal Health Corporation
Virbac
Vetoquinol
HIPRA
Ceva
Dechra
Kyoritsuseiyaku Corporation
Endovac Animal Health
Zydus Group
Indian Immunologicals Pvt. Ltd
UCBVET Sa煤de e Bem Estar Animal
American Reagent Inc
Neogen Corporation
Huvepharma
China Animal Husbandry Group
听
听
*If Applicable.